Cargando…

Ultrasound-triggered herceptin liposomes for breast cancer therapy

The functionalization of liposomes with monoclonal antibodies is a potential strategy to increase the specificity of liposomes and reduce the side-effects associated with chemotherapeutic agents. The active targeting of the Human Epidermal growth factor Receptor 2 (HER2), which is overexpressed in H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elamir, Amal, Ajith, Saniha, Sawaftah, Nour Al, Abuwatfa, Waad, Mukhopadhyay, Debasmita, Paul, Vinod, Al-Sayah, Mohammad H., Awad, Nahid, Husseini, Ghaleb A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024284/ https://www.ncbi.nlm.nih.gov/pubmed/33824356 http://dx.doi.org/10.1038/s41598-021-86860-5

Ejemplares similares

Transferrin-modified liposomes triggered with ultrasound to treat HeLa cells
por: AlSawaftah, Nour M., et al.
Publicado: (2021)

Ultrasound-Triggered Liposomes Encapsulating Quantum Dots as Safe Fluorescent Markers for Colorectal Cancer
por: Awad, Nahid S., et al.
Publicado: (2021)

Effect of phospholipid head group on ultrasound-triggered drug release and cellular uptake of immunoliposomes
por: Awad, Nahid S., et al.
Publicado: (2023)

Ultrasound Triggering of Liposomal Nanodrugs for Cancer Therapy: A Review
por: Bahutair, Wafa N., et al.
Publicado: (2022)

A Review on Membrane Biofouling: Prediction, Characterization, and Mitigation
por: AlSawaftah, Nour, et al.
Publicado: (2022)

Thermosensitive Polymers and Thermo-Responsive Liposomal Drug Delivery Systems
por: Abuwatfa, Waad H., et al.
Publicado: (2022)

A Review on Membrane Fouling Prediction Using Artificial Neural Networks (ANNs)
por: Abuwatfa, Waad H., et al.
Publicado: (2023)

Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review
por: Ibrahim, Mihad, et al.
Publicado: (2022)

Acoustically-Activated Liposomal Nanocarriers to Mitigate the Side Effects of Conventional Chemotherapy with a Focus on Emulsion-Liposomes
por: Zafar, Mah Noor, et al.
Publicado: (2023)

Liposomes for the Treatment of Brain Cancer—A Review
por: Raju, Richu, et al.
Publicado: (2023)

Gold-Nanoparticle Hybrid Nanostructures for Multimodal Cancer Therapy
por: Ali, Amaal Abdulraqeb, et al.
Publicado: (2022)

Transferrin-Targeted Liposomes in Glioblastoma Therapy: A Review
por: Kawak, Paul, et al.
Publicado: (2023)

pH-Responsive Nanocarriers in Cancer Therapy
por: AlSawaftah, Nour M., et al.
Publicado: (2022)

Recent Advances in Nanoparticle-Based Co-Delivery Systems for Cancer Therapy
por: Al Bostami, Rouba D., et al.
Publicado: (2022)

Nanoparticle-based materials in anticancer drug delivery: Current and future prospects
por: Ajith, Saniha, et al.
Publicado: (2023)

Redox-Responsive Drug Delivery Systems: A Chemical Perspective
por: Abed, Heba F., et al.
Publicado: (2022)

Photo-Induced Drug Release from Polymeric Micelles and Liposomes: Phototriggering Mechanisms in Drug Delivery Systems
por: Salkho, Najla M., et al.
Publicado: (2022)

Anticancer Effect of Metformin in Herceptin-Conjugated Liposome for Breast Cancer
por: Lee, Ji-Yeon, et al.
Publicado: (2019)

Modeling of the In Vitro Release Kinetics of Sonosensitive Targeted Liposomes
por: AlMajed, Zeyad, et al.
Publicado: (2022)

Psoriasis Induced by Trastuzumab (Herceptin®)
por: Kim, Dae Hun, et al.
Publicado: (2013)

The role of Herceptin in early breast cancer
por: Subramanian, Ashok, et al.
Publicado: (2008)

Herceptin in clinical use - early 2000
por: Vogel, CL
Publicado: (2000)

Mild hyperthermia influence on Herceptin(®) properties
por: Escoffre, Jean-Michel, et al.
Publicado: (2015)

Development of Liposome-Based Immunoassay for the Detection of Cardiac Troponin I
por: Radha, Remya, et al.
Publicado: (2021)

The chemomodulatory effects of resveratrol and didox on herceptin cytotoxicity in breast cancer cell lines
por: Abdel-Latif, Ghada A., et al.
Publicado: (2015)

Transgenic models are predictive: the herceptin and flavopiridol experience
por: Schmidt, E
Publicado: (2003)

Herceptin clinical trials: past, present and future
por: Vogel, CL
Publicado: (2001)

Internalization: acute apoptosis of breast cancer cells using herceptin-immobilized gold nanoparticles
por: Rathinaraj, Pierson, et al.
Publicado: (2015)

Let-7 miRNA and CDK4 siRNA co-encapsulated in Herceptin-conjugated liposome for breast cancer stem cells
por: Shin, Jeong Hyun, et al.
Publicado: (2020)

Ultrasound‐Triggered Delivery of Iproplatin from Microbubble‐Conjugated Liposomes
por: Browning, Richard, et al.
Publicado: (2021)

Combinatorial experimental protocols for Erbicin-derived immunoagents and Herceptin
por: De Lorenzo, C, et al.
Publicado: (2007)

Radiation Recall Reaction Induced by Adjuvant Trastuzumab (Herceptin)
por: Chung, Caroline, et al.
Publicado: (2009)

Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance
por: Jiang, Jin, et al.
Publicado: (2022)

Microwave Imaging for Early Breast Cancer Detection: Current State, Challenges, and Future Directions
por: AlSawaftah, Nour, et al.
Publicado: (2022)

Liposomes-Based Drug Delivery Systems of Anti-Biofilm Agents to Combat Bacterial Biofilm Formation
por: Makhlouf, Zinb, et al.
Publicado: (2023)

Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice
por: Yousif, Nasser Ghaly, et al.
Publicado: (2011)

Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
por: Schwall, RH, et al.
Publicado: (2003)

Serological Her2/neu-determination in patients receiving Herceptin(®)
por: Thomas, A, et al.
Publicado: (2001)

Safety of trastuzumab (Herceptin(®)) during pregnancy: two case reports
por: Goodyer, Matthew J, et al.
Publicado: (2009)

Exogenous Contrast Agents in Photoacoustic Imaging: An In Vivo Review for Tumor Imaging
por: Farooq, Afifa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cbonh0c33dchn4fuh6igssmshd